Increased ET-1 and Reduced ET_B Receptor Expression in Uremic Hypertensive Rats

REFERENCES

• Larivière R, Lebel M. Endothelin-1 in chronic renal failure and hypertension. Can J Physiol Pharmacol 2003;81:607–621.
   PubMed Web of Science ®Google Scholar
• Koyama H, Nishzawa Y, Morii H, Tabata T, Inoue T, Yamaji T. Plasma endothelin levels in patients with uremia. Lancet 1989;1:991–992.
   PubMed Web of Science ®Google Scholar
• Lebel M, Grose JH, Kingma I, Langlois S. Plasma endothelin levels and blood pressure in hemodialysis and in CAPD patients: Effect of subcutaneous erythropoietin replacement therapy. Clin Exper Hypertens 1994;16:565–575.
   PubMed Web of Science ®Google Scholar
• Larivière R, D'Amours M, Lebel M, Kingma I, Grose JH, Caron L. Increased immunoreactive endothelin-1 levels in blood vessels and glomeruli of rats with reduced renal mass. Kidney Blood Pressure Res 1997;20:372–380.
   PubMed Web of Science ®Google Scholar
• Larivière R, Lebel M, Kingma I, Grose JH, Boucher D. Effects of losartan and captopril on endothelin-1 production in blood vessels and glomeruli of rats with reduced renal mass. Am J Hypertens 1998;11:989–997.
   PubMed Web of Science ®Google Scholar
• Dumont Y, D'Amours M, Lebel M, Larivière R. Blood pressure-independent effects of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats. J Hypertens 2001;19:1479–1487.
   PubMed Web of Science ®Google Scholar
• Dhaun N, Goddard J, Webb DJ. The endothelin system and its antagonism in chronic kidney disease. J Am Soc Nephrol 2006;17:943–955.
   PubMed Web of Science ®Google Scholar
• Brochu E, Lacasse-M. S, Moreau C, Lebel M, Kingma I, Grose JH, Larivière R. Endothelin ETA receptor blockade prevents the progression of renal failure and hypertension in uremic rats. Nephrol Dial Transplant 1999;14:1881–1888.
   PubMed Web of Science ®Google Scholar
• Benigni A, Zoja C, Corna D, Orisio S, Longaretti L, Bertani T, Remuzzi G. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 1993;44:440–444.
   PubMed Web of Science ®Google Scholar
• Seo B, Oemar BS, Siebenmann R, von Segesser L, Lüscher TF. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994;89:1203–1208.
   PubMed Web of Science ®Google Scholar
• Haynes WG, Strachan FE, Gray GA, Webb DJ. Forearm vasoconstriction to endothelin-1 is mediated by ETA and ETB receptors in vivo in humans. J Cardiovasc Pharmacol 1995;26 (suppl. 3):S40–S43.
   PubMedGoogle Scholar
• Lehrke I, Waldherr R, Ritz E, Wagner J. Renal endothelin-1 and endothelin receptor type B expression in glomerular diseases with proteinuria. J Am Soc Nephrol 2001;12:2321–2329.
   PubMed Web of Science ®Google Scholar
• Tirapelli CR, Casolari DA, Yogi A, Montezano AC, Tostes RC, Legros E, D'Orleans-Juste P, de Oliveira AM. Functional characterization and expression of endothelin receptors in rat carotid artery: Involvement of nitric oxide, a vasodilator prostanoid and the opening of K(+) channels in ET(B)-induced relaxation. Br J Pharmacol 2005;146:903–912.
   PubMed Web of Science ®Google Scholar
• Inscho EW, Imig JD, Cook AK, Pollock DM. ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin. Br J Pharmacol 2005;146: 1019–1026.
   PubMed Web of Science ®Google Scholar
• Boulanger C, Lüscher TF. Release of endothelin from the porcine aorta: Inhibition by endothelium-derived nitric oxide. J Clin Invest 1990;85:587–590.
   PubMed Web of Science ®Google Scholar
• Filep JG, Foldes-FilepÉ, Rousseau A, Sirois P, Fournier A. Vascular responses to endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat. Br J Pharmacol 1993;110:1213–1221.
   PubMed Web of Science ®Google Scholar
• Gariepy CE, Ohuchi T, Williams SC, Richardson JA, Yanagisawa M. Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest 2000;105:925–933.
   PubMed Web of Science ®Google Scholar
• Hocher B, Dembowski C, Slowinski T, Friese ST, Schwarz A, Siren AL, Neumayer HH, Thone-Reineke C, Bauer C, Nafz B, Ehrenreich H. Impaired sodium excretion, decreased glomerular filtration rate and elevated blood pressure in endothelin receptor type B deficient rats. J Mol Med 2001; 78:633–641.
   PubMed Web of Science ®Google Scholar
• Matsuura T, Miura K, Ebara T, Yukimura T, Yamanaka S, Kim S, Iwao H. Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats. Br J Pharmacol 1997;122:81–86.
   PubMed Web of Science ®Google Scholar
• Gratton J, Cournoyer G, Loffler BM, Sirois P, D'Orléans-Juste P. ETB receptor and nitric oxide synthase blockade induce BQ-123-sensitive pressor effects in the rabbit. Hypertension 1997;30:1204–1209.
   PubMed Web of Science ®Google Scholar
• Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 1994;199: 1461–1465.
   PubMed Web of Science ®Google Scholar
• Brunner F, Doherty A. Role of ETB receptor in local clearance of endothelin-1 in rat heart: Studies with the antagonists PD 155080 and BQ-123. FEBS Lett 1996;396:238–242.
   PubMed Web of Science ®Google Scholar
• Goddard J, Johnston NR, Hand MF, Cumming AD, Rabelink TJ, Rankin AJ, Webb DJ. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: A comparison of selective and combined endothelin receptor blockade. Circulation 2004;109:1186–1193.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Hata S, Kuroda T, Mihara S, Fujimoto M. Different roles of two types of endothelin receptors in partial ablation-induced chronic renal failure in rats. Eur J Pharmacol 1999;381:39–49.
   PubMed Web of Science ®Google Scholar
• Okada Y, Nakata M, Izumoto H, Takasu M, Tazawa N, Takaoka M, Gariepy CE, Yanagisawa M, Matsumura Y. Role of endothelin ET(B) receptor in partial ablation-induced chronic renal failure in rats. Eur J Pharmacol 2004;494:63–71.
   PubMed Web of Science ®Google Scholar
• Lavoie P, Robitaille G, Agharazii M, Ledbetter S, Lebel M, Larivière R. Neutralization of transforming growth factor-b attenuates hypertension and prevents renal injury in uremic rats. J Hypertens 2005;23:1895–1903.
   PubMed Web of Science ®Google Scholar
• Rodrigue ME, Brochu I, D'Orleans-Juste P, Lariviere R, Lebel M. Effect of erythropoietin on blood pressure and on the vascular endothelial ET-1/ETB receptor system. Am J Hypertens 2008; 21:639–643.
   PubMed Web of Science ®Google Scholar
• Thibault G, Doubell A, Garcia R, Larivière R, Schiffrin EL. Endothelin-stimulated secretion of natriuretic peptides by rat myocytes is mediated by endothelin A receptors. Circ Res 1994;74:460–470.
   PubMed Web of Science ®Google Scholar
• Berthiaume N, Yanagisawa M, Labonte J, D'Orléans-Juste P. Heterozygous knock-out of ETB receptors induces BQ-123-sensitive hypertension in the mouse. Hypertension 2000;36: 1002–1007.
   PubMed Web of Science ®Google Scholar
• Larivière R, Thibault G, Schiffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not spontaneously hypertensive rats. Hypertension 1993;21:294–300.
   PubMed Web of Science ®Google Scholar
• Dumont Y, D'Amours M, Lebel M, Larivière R. Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats. Nephrol Dial Transplant 2001;16:746–754.
   PubMed Web of Science ®Google Scholar
• Benigni A, Perico N, Gaspari F, Zoja C, Bellizzi L, Gabanelli M, Remuzzi G. Increased renal endothelin production in rats with reduced renal mass. Am J Physiol 1991;260:F331–F339.
   PubMed Web of Science ®Google Scholar
• Abassi ZA, Tate JE, Golomb E, Keiser HR. Role of neutral endopeptidase in the metabolism of endothelin. Hypertension 1992;20:89–95.
   PubMed Web of Science ®Google Scholar
• De Nucci G, Thomas R, D'Orléans-Juste P, Antunes E, Walder C, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988;85:9797–9800.
   PubMed Web of Science ®Google Scholar
• Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K, Marumo F. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 1993;91:1367–1373.
   PubMed Web of Science ®Google Scholar
• Tostes Passaglia RC, David FL, Fortes ZB, Nigro D, Scivoletto R, Catelli De Carvalho MH. Deoxycorticosterone acetate-salt hypertensive rats display gender-related differences in ET(B) receptor-mediated vascular responses. Br J Pharmacol 2000;130:1092–1098.
   PubMed Web of Science ®Google Scholar
• Morris ST, McMurray JJ, Spiers A, Jardine AG. Impaired endothelial function in isolated human uremic resistance arteries. Kidney Int 2001;60:1077–1082.
   PubMed Web of Science ®Google Scholar
• Kakoki M, Hirata Y, Hayakawa H, Tojo A, Nagata D, Suzuki E, Kimura K, Goto A, Kikuchi K, Nagano T, Omata M. Effects of hypertension, diabetes mellitus, and hypercholesterolemia on endothelin type B receptor-mediated nitric oxide release from rat kidney. Circulation 1999;99: 1242–1248.
   PubMed Web of Science ®Google Scholar
• Pfab T, Thone-Reineke C, Theilig F, Lange I, Witt H, Maser-Gluth C, Bader M, Stasch JP, Ruiz P, Bachmann S, Yanagisawa M, Hocher B. Diabetic endothelin B receptor-deficient rats develop severe hypertension and progressive renal failure. J Am Soc Nephrol 2006;17:1082–1089.
   PubMed Web of Science ®Google Scholar
• Sakurai T, Morimoto H, Kasuya Y, Takuwa Y, Nakauchi H, Masaki T, Goto K. Level of ETB receptor mRNA is down-regulated by endothelins through decreasing the intracellular stability of mRNA molecules. Biochem Biophys Res Commun 1992;186:342–347.
   PubMed Web of Science ®Google Scholar
• Hocher B, Schwarz A, Slowinski T, Bachmann S, Pfeilschifter J, Neumayer HH, Bauer C. In-vivo interaction of nitric oxide and endothelin. J Hypertens 2004;22:111–119.
   PubMed Web of Science ®Google Scholar
• Bremnes T, Paasche JD, Mehlum A, Sandberg C, Bremnes B, Attramadal H. Regulation and intracellular trafficking pathways of the endothelin receptors. J Biol Chem 2000;275: 17596–17604.
   PubMed Web of Science ®Google Scholar
• Abe Y, Nakayama K, Yamanaka A, Sakurai T, Goto K. Subtype-specific trafficking of endothelin receptors. J Biol Chem 2000;275:8664–8671.
   PubMed Web of Science ®Google Scholar